OVERVIEW

Emerging Research & Trial Strategies for Progressive Multiple Sclerosis is organized by The New York Academy of Sciences (NYAS) and will be held on Oct 04, 2021.

Description:
Despite being the most common progressive neurologic disease in young adults worldwide, no treatment is available for progressive forms of multiple sclerosis (MS). Furthermore, advances in disease-modifying therapeutics for relapsing-remitting MS have little to no efficacy for progressive MS. This is due in part to an incomplete understanding of the disease mechanism and a lack of validated outcome measures for clinical trials.

To advance scientific understanding and therapies to treat progressive MS patients, this 1-day virtual symposium will convene physician-scientists, academics, industry leaders, and clinicians to discuss recent basic and clinical research and offer new targets and modalities to be tested as treatments. Session topics include research on innate immune response and cells as therapeutic targets, advances in biomarkers to assess disease progression and monitor response to therapy, and insights into Phase 2 and Phase 3 clinical trial design.